Vanguard (NYSE: ASPN) amendment shows 0 shares; reporting reorganization
Rhea-AI Filing Summary
The Vanguard Group filed Amendment No. 2 to a Schedule 13G/A reporting 0 shares of Aspen Aerogels Inc. common stock, representing 0% of the class as reported. The filing explains an internal realignment dated January 12, 2026 that led certain Vanguard subsidiaries to report disaggregated holdings separately.
Positive
- None.
Negative
- None.
Insights
Vanguard reports no beneficial ownership after internal realignment.
The filing states 0 shares and 0% ownership for Aspen Aerogels common stock in this amendment. It attributes the change to an internal realignment of The Vanguard Group on January 12, 2026, which caused certain subsidiaries to report holdings separately in reliance on SEC Release No. 34-39538.
Cash‑flow treatment and any prior holdings are not described in the excerpt; subsequent filings from Vanguard or the company would show any holder-level activity resulting from the disaggregation.
Administrative reporting change, not an economic transaction by Aspen Aerogels.
The amendment documents reporting structure changes within Vanguard rather than a sale or purchase of Aspen Aerogels shares: the filing lists voting and dispositive powers as 0 across the board. The statement cites reliance on SEC Release No. 34-39538 for disaggregation.
Because this is a disclosure of beneficial‑ownership reporting allocation, its investor impact is routine; any material ownership changes would appear in related filings showing positive share counts.
AI-generated analysis. How Rhea-AI works. Not financial advice.